Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Fulgent Genetics, Inc. (FLGT) had Normalized Income after Taxes of $-50.52M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$322.67M |
|
$-60.51M |
|
$191.80M |
|
$130.88M |
|
$413.77M |
|
$-91.10M |
|
$21.07M |
|
$-70.03M |
|
$-60.10M |
|
$-61.63M |
|
$-61.63M |
|
$-61.63M |
|
|
Normalized Income after Taxes |
$-50.52M |
$-91.10M |
|
$-91.10M |
|
30.78M |
|
30.78M |
|
$-1.97 |
|
$-1.97 |
|
| Balance Sheet Financials | |
$790.11M |
|
$112.55M |
|
$423.42M |
|
$1.21B |
|
$106.81M |
|
-- |
|
-- |
|
$106.81M |
|
-- |
|
$1.11B |
|
$1.11B |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|